August 11, 2019

August 11, 2019

ASH 2018: Dr. Nabhan on Patient Reported Outcomes (PROs) in Malignant Hematology

At ASH 2018, Dr. Nabhan discussed the importance of Patient Reported Outcomes or PROs in not only research, but in improving patient outcomes. It should be obvious that the best source of information about patient outcomes is listening to the patients. Research has shown that simply listening to the

August 11, 2019

Biosimilars

“Biosimilars” are equivalent versions of monoclonal antibodies that have previously been FDA approved to treat various diseases. Because antibodies are more complicated than simple drugs like acetaminophen and aspirin, etc., these drugs are not chemically identical to the original drug. The main advantage of biosimilars is the reduction in

August 11, 2019

ASH 2018: Dr. Neil Kay on how Stromal Cells Keep CLL (chronic lymphocytic leukemia) Cells Alive in the Bone Marrow and How we Can Intervene

At ASH 2018 in San Diego, CA, I interviewed Dr. Neil Kay out of Mayo Clinic, Rochester, MN, an innovative chronic lymphocytic leukemia researcher who besides caring for CLL patients and conducting clinical trials, is doing important “bench” science where we are fortunate to find insights that can transform

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

August 11, 2019

ASH 2018: Dr. Nabhan on Patient Reported Outcomes (PROs) in Malignant Hematology

Biosimilars

ASH 2018: Dr. Neil Kay on how Stromal Cells Keep CLL (chronic lymphocytic leukemia) Cells Alive in the Bone Marrow and How we Can Intervene

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT